Search

everythinglearnresearchcommunity

for

Search:↓

A bladder rupture from prostate treatment was healed with catheterization and antibiotics.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Men over 50 often experience urinary issues due to prostate enlargement or bladder problems, treatable with therapies, medications, or surgery.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

Early intervention for acute urinary retention can reduce costs and improve care.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Cutaneous vesicostomy and cystoscopic valve ablation both have pros and cons for managing posterior urethral valves.

Botulinum toxin is used in many medical fields beyond cosmetic purposes.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Cancer prevention has advanced significantly, with some strategies proving successful.

African plum is linked to treating BPH and has economic benefits.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

Selenium supplements do not prevent cancer and may have harmful effects.

Involucrin is a useful marker for keratinocyte differentiation in mice.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Early detection and treatment of urinary symptoms can help maintain functional ability in older adults.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.